Overall, these results provide hypothesis-generating insights that may guide future studies evaluating whether modulation of the miR-21–PTEN–PI3K/AKT axis can influence the tumor immune microenvironment or enhance immunotherapeutic responses in colorectal cancer. The gene discussed is AKT1; the disease is neoplasm.